Mitsu Chem Plast Reports Strong Profit Growth Following Earnings Clarification

Mitsu Chem Plast Ltd. has announced significant year-on-year profit growth for its fourth quarter and full fiscal year, following a clarification regarding its earnings reporting unit. The company reported a net profit of ₹771.73 lakh for Q4 FY26, marking a substantial 117.90% increase from the ₹354.17 lakh recorded in the same period last year. For the full fiscal year FY26, net profit surged 115.40% to ₹1561.87 lakh, up from FY25.

The company issued a correction, specifying that its financial figures were reported in 'Lakhs' rather than the previously stated 'Crores'.

This strong profitability is underpinned by strategic business developments. Mitsu Chem Plast is expanding into the Intermediate Bulk Container (IBC) vertical, leveraging its established packaging expertise. Furthermore, a global supply agreement for medical equipment positions the company within the healthcare sector and opens new export avenues.

The company is also actively pursuing capacity expansion, planning to add approximately 900 metric tons per annum to its existing capacity. This initiative aims to lift total installed capacity beyond 29,900 MT per annum, supporting anticipated future demand. The new Boisar facility is also expected to contribute to the production base.

Beyond net profit, EBITDA for Q4 FY26 grew by 72.98% to ₹1422.74 lakh, and Earnings Per Share (EPS) for the quarter rose 117.62% to ₹5.68. However, investors will monitor the 4.10% decline in Total Income for Q4 FY26, which fell to ₹8679.47 lakh from ₹9050.68 lakh in the prior year, to ensure revenue growth resumes.

In the broader plastics and packaging market, competitors like Supreme Industries and Nilkamal operate at different scales. Supreme Industries reported FY24 revenue of ₹6,360 crore and profit of ₹446 crore, while Nilkamal posted FY24 consolidated revenue of ₹2,658 crore and profit of ₹144 crore. Mitsu Chem Plast's reported FY26 figures, with revenue at ₹350.85 crore and profit at ₹15.62 crore, indicate a company operating at a smaller but rapidly growing scale.

Key areas to watch for Mitsu Chem Plast include the ramp-up of operations at its new Boisar facility, the performance and revenue generation from the IBC segment, and the impact of the global medical equipment agreement on export revenues. Management's commentary on the capacity expansion project's progress and signs of renewed total income growth in upcoming quarters will also be important.